 Natarajavelalar Balasubramaniyan
Concepts (340)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholestasis | 10 | 2023 | 207 | 1.550 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 13 | 2021 | 209 | 1.160 |
Why?
| | Transcriptional Activation | 5 | 2016 | 378 | 0.920 |
Why?
| | ATP-Binding Cassette Transporters | 11 | 2016 | 120 | 0.850 |
Why?
| | Gene Expression Regulation | 11 | 2021 | 2599 | 0.840 |
Why?
| | Liver | 14 | 2024 | 1819 | 0.820 |
Why?
| | Transcription Factor RelA | 3 | 2024 | 85 | 0.730 |
Why?
| | MicroRNAs | 2 | 2021 | 689 | 0.560 |
Why?
| | Hepatocytes | 7 | 2024 | 211 | 0.520 |
Why?
| | Bile Acids and Salts | 10 | 2023 | 151 | 0.500 |
Why?
| | Response Elements | 1 | 2016 | 90 | 0.470 |
Why?
| | Sumoylation | 1 | 2013 | 16 | 0.400 |
Why?
| | Histone-Lysine N-Methyltransferase | 2 | 2012 | 134 | 0.400 |
Why?
| | NF-kappa B | 4 | 2024 | 692 | 0.390 |
Why?
| | Uterine Cervical Neoplasms | 4 | 1995 | 287 | 0.340 |
Why?
| | Gene Expression Regulation, Developmental | 6 | 2012 | 874 | 0.320 |
Why?
| | Endotoxemia | 2 | 2024 | 87 | 0.310 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2024 | 1250 | 0.310 |
Why?
| | Mice | 20 | 2025 | 18048 | 0.280 |
Why?
| | Animals | 36 | 2025 | 37657 | 0.270 |
Why?
| | Promoter Regions, Genetic | 10 | 2016 | 1242 | 0.270 |
Why?
| | Parenteral Nutrition | 3 | 2021 | 105 | 0.240 |
Why?
| | Protein Binding | 6 | 2016 | 2239 | 0.230 |
Why?
| | Organic Anion Transporters, Sodium-Dependent | 6 | 2011 | 14 | 0.230 |
Why?
| | Kidney | 3 | 2012 | 1482 | 0.220 |
Why?
| | Symporters | 6 | 2011 | 45 | 0.220 |
Why?
| | Carrier Proteins | 6 | 2020 | 740 | 0.220 |
Why?
| | Signal Transduction | 7 | 2025 | 5144 | 0.210 |
Why?
| | Transcription Factors | 7 | 2016 | 1703 | 0.210 |
Why?
| | Transcription Factor AP-1 | 1 | 2024 | 88 | 0.210 |
Why?
| | Mice, Inbred C57BL | 7 | 2025 | 5887 | 0.210 |
Why?
| | RNA, Messenger | 14 | 2023 | 2828 | 0.190 |
Why?
| | Membrane Glycoproteins | 4 | 2020 | 501 | 0.190 |
Why?
| | Acetaminophen | 1 | 2025 | 262 | 0.190 |
Why?
| | Glycoproteins | 2 | 1995 | 356 | 0.190 |
Why?
| | Animals, Newborn | 2 | 2024 | 863 | 0.190 |
Why?
| | Cholangitis, Sclerosing | 1 | 2023 | 56 | 0.190 |
Why?
| | Mice, Knockout | 5 | 2025 | 3068 | 0.180 |
Why?
| | Chenodeoxycholic Acid | 1 | 2021 | 12 | 0.180 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 1 | 2021 | 15 | 0.180 |
Why?
| | Isoxazoles | 1 | 2021 | 54 | 0.180 |
Why?
| | Membrane Transport Proteins | 5 | 2007 | 156 | 0.180 |
Why?
| | Cell Line | 8 | 2020 | 2885 | 0.170 |
Why?
| | Macrophages | 3 | 2021 | 1561 | 0.170 |
Why?
| | Chromatin | 3 | 2015 | 529 | 0.170 |
Why?
| | Gene Expression | 2 | 2024 | 1491 | 0.160 |
Why?
| | Interleukin-1beta | 2 | 2021 | 380 | 0.160 |
Why?
| | DNA-Binding Proteins | 6 | 2013 | 1478 | 0.150 |
Why?
| | Disease Models, Animal | 4 | 2024 | 4404 | 0.150 |
Why?
| | Biliary Atresia | 1 | 2020 | 153 | 0.150 |
Why?
| | RNA, Small Interfering | 4 | 2016 | 626 | 0.140 |
Why?
| | Receptors, CCR2 | 1 | 2018 | 39 | 0.140 |
Why?
| | Immunity, Innate | 1 | 2024 | 852 | 0.140 |
Why?
| | Biomarkers, Tumor | 2 | 1995 | 1251 | 0.130 |
Why?
| | Protein Transport | 4 | 2013 | 448 | 0.130 |
Why?
| | Nuclear Receptor Co-Repressor 2 | 1 | 2016 | 14 | 0.120 |
Why?
| | Methylation | 3 | 2012 | 230 | 0.120 |
Why?
| | 5-Methylcytosine | 1 | 2016 | 22 | 0.120 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2013 | 377 | 0.120 |
Why?
| | Amino Acid Substitution | 3 | 2013 | 310 | 0.120 |
Why?
| | I-kappa B Proteins | 1 | 2015 | 76 | 0.120 |
Why?
| | Radioisotope Teletherapy | 1 | 1995 | 2 | 0.110 |
Why?
| | Cobalt Radioisotopes | 1 | 1995 | 7 | 0.110 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 145 | 0.110 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2015 | 18 | 0.110 |
Why?
| | Lipid Peroxides | 1 | 1994 | 10 | 0.110 |
Why?
| | Histones | 3 | 2012 | 639 | 0.110 |
Why?
| | Apoptosis | 1 | 2024 | 2574 | 0.110 |
Why?
| | Glycoside Hydrolases | 1 | 1995 | 39 | 0.110 |
Why?
| | Haplorhini | 2 | 2012 | 53 | 0.110 |
Why?
| | Sialic Acids | 1 | 1994 | 8 | 0.110 |
Why?
| | Histone Deacetylases | 1 | 2016 | 209 | 0.110 |
Why?
| | Trans-Activators | 2 | 2008 | 388 | 0.110 |
Why?
| | Glycolipids | 1 | 1994 | 44 | 0.110 |
Why?
| | Endothelin-1 | 1 | 2015 | 177 | 0.100 |
Why?
| | Brachytherapy | 1 | 1995 | 130 | 0.100 |
Why?
| | Cadmium | 1 | 1994 | 68 | 0.100 |
Why?
| | Rats | 11 | 2009 | 5629 | 0.100 |
Why?
| | Genetic Loci | 1 | 2015 | 277 | 0.100 |
Why?
| | DNA Helicases | 1 | 2015 | 140 | 0.100 |
Why?
| | Small Ubiquitin-Related Modifier Proteins | 1 | 2013 | 14 | 0.100 |
Why?
| | Protein Processing, Post-Translational | 2 | 2013 | 464 | 0.100 |
Why?
| | Consensus Sequence | 1 | 2013 | 74 | 0.100 |
Why?
| | SUMO-1 Protein | 1 | 2013 | 21 | 0.100 |
Why?
| | Hep G2 Cells | 1 | 2013 | 71 | 0.100 |
Why?
| | Copper | 1 | 1994 | 114 | 0.100 |
Why?
| | Glutathione | 1 | 1994 | 356 | 0.100 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2012 | 16 | 0.100 |
Why?
| | Inflammation | 2 | 2023 | 2890 | 0.100 |
Why?
| | Cholesterol 7-alpha-Hydroxylase | 2 | 2003 | 2 | 0.100 |
Why?
| | Amino Acid Motifs | 1 | 2013 | 225 | 0.100 |
Why?
| | Multidrug Resistance-Associated Proteins | 3 | 2021 | 35 | 0.100 |
Why?
| | Lysine | 2 | 2013 | 292 | 0.100 |
Why?
| | Cell Membrane | 2 | 2007 | 724 | 0.090 |
Why?
| | Zebrafish | 3 | 2002 | 500 | 0.090 |
Why?
| | Carcinoma | 1 | 1994 | 230 | 0.090 |
Why?
| | Lung | 1 | 2025 | 4134 | 0.090 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 330 | 0.090 |
Why?
| | Embryonic Stem Cells | 1 | 2012 | 129 | 0.090 |
Why?
| | Nuclear Receptor Coactivators | 1 | 2011 | 2 | 0.090 |
Why?
| | Neoplasm Proteins | 1 | 1994 | 432 | 0.090 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 348 | 0.090 |
Why?
| | Macrophage Activation | 2 | 2023 | 200 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 601 | 0.090 |
Why?
| | Zinc | 1 | 1994 | 299 | 0.080 |
Why?
| | Adenosine Triphosphatases | 2 | 2008 | 159 | 0.080 |
Why?
| | Steroid Hydroxylases | 3 | 2004 | 19 | 0.080 |
Why?
| | Male | 12 | 2021 | 69783 | 0.080 |
Why?
| | Humans | 24 | 2023 | 141187 | 0.080 |
Why?
| | Organotechnetium Compounds | 1 | 2009 | 11 | 0.080 |
Why?
| | Cell Line, Tumor | 2 | 2016 | 3469 | 0.080 |
Why?
| | Imino Acids | 1 | 2009 | 6 | 0.080 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2009 | 11 | 0.080 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1994 | 642 | 0.080 |
Why?
| | Cell Cycle | 1 | 2012 | 597 | 0.080 |
Why?
| | Transcription, Genetic | 3 | 2013 | 1487 | 0.080 |
Why?
| | Lipoproteins | 2 | 2021 | 163 | 0.070 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2008 | 14 | 0.070 |
Why?
| | Arginine | 2 | 2013 | 260 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2008 | 56 | 0.070 |
Why?
| | Adenocarcinoma | 1 | 1994 | 892 | 0.070 |
Why?
| | Protein Kinase C | 1 | 2008 | 252 | 0.070 |
Why?
| | Base Sequence | 5 | 2016 | 2180 | 0.060 |
Why?
| | Transfection | 5 | 2008 | 943 | 0.060 |
Why?
| | Bile Ducts | 2 | 2020 | 66 | 0.060 |
Why?
| | Molecular Chaperones | 1 | 2008 | 198 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1010 | 0.060 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2025 | 30 | 0.060 |
Why?
| | Sterols | 2 | 2021 | 20 | 0.060 |
Why?
| | Cholesterol | 2 | 2004 | 405 | 0.060 |
Why?
| | Organic Anion Transporters | 1 | 2005 | 11 | 0.060 |
Why?
| | Bile Canaliculi | 1 | 2004 | 4 | 0.060 |
Why?
| | Bile | 1 | 2004 | 25 | 0.060 |
Why?
| | Caco-2 Cells | 3 | 2013 | 78 | 0.060 |
Why?
| | Down-Regulation | 4 | 2011 | 641 | 0.060 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 94 | 0.060 |
Why?
| | Binding Sites | 5 | 2008 | 1316 | 0.060 |
Why?
| | Serine | 1 | 2005 | 148 | 0.050 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2004 | 25 | 0.050 |
Why?
| | Molecular Sequence Data | 5 | 2013 | 2929 | 0.050 |
Why?
| | Vacuolar Proton-Translocating ATPases | 1 | 2004 | 15 | 0.050 |
Why?
| | Homeostasis | 2 | 2024 | 636 | 0.050 |
Why?
| | Antioxidants | 2 | 2023 | 595 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2024 | 57 | 0.050 |
Why?
| | Methyltransferases | 2 | 2016 | 72 | 0.050 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2024 | 73 | 0.050 |
Why?
| | STAT3 Transcription Factor | 1 | 2025 | 204 | 0.050 |
Why?
| | Thioredoxin Reductase 1 | 1 | 2023 | 8 | 0.050 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 2012 | 336 | 0.050 |
Why?
| | Taurocholic Acid | 3 | 2007 | 8 | 0.050 |
Why?
| | Hydroxysteroid Dehydrogenases | 1 | 2002 | 1 | 0.050 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2002 | 93 | 0.050 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2002 | 44 | 0.050 |
Why?
| | Hypercholesterolemia | 1 | 2003 | 101 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 84 | 0.040 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 156 | 0.040 |
Why?
| | Intestinal Diseases | 1 | 2021 | 42 | 0.040 |
Why?
| | Bilirubin | 1 | 2021 | 90 | 0.040 |
Why?
| | Infliximab | 1 | 2021 | 111 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2005 | 968 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 792 | 0.040 |
Why?
| | CD79 Antigens | 1 | 2020 | 16 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2023 | 282 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2024 | 889 | 0.040 |
Why?
| | Mitochondria | 1 | 2025 | 967 | 0.040 |
Why?
| | Plasmids | 2 | 2011 | 365 | 0.040 |
Why?
| | Liver Diseases | 1 | 2021 | 301 | 0.040 |
Why?
| | Retinoid X Receptors | 2 | 2013 | 38 | 0.040 |
Why?
| | Caspases, Initiator | 1 | 2018 | 17 | 0.040 |
Why?
| | Liver X Receptors | 1 | 2018 | 30 | 0.040 |
Why?
| | Lipids | 1 | 2003 | 689 | 0.040 |
Why?
| | Endothelial Growth Factors | 1 | 1998 | 65 | 0.040 |
Why?
| | Lymphokines | 1 | 1998 | 133 | 0.030 |
Why?
| | Amino Acid Sequence | 3 | 2013 | 2158 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 147 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2018 | 215 | 0.030 |
Why?
| | Caspases | 1 | 2018 | 245 | 0.030 |
Why?
| | Lipid Peroxidation | 2 | 1994 | 150 | 0.030 |
Why?
| | COS Cells | 2 | 2007 | 183 | 0.030 |
Why?
| | Phosphofructokinase-1 | 1 | 2016 | 6 | 0.030 |
Why?
| | Heme Oxygenase (Decyclizing) | 1 | 2016 | 22 | 0.030 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2016 | 41 | 0.030 |
Why?
| | Blotting, Western | 2 | 2012 | 1234 | 0.030 |
Why?
| | Sirtuin 1 | 1 | 2016 | 33 | 0.030 |
Why?
| | Phosphorylation | 2 | 2012 | 1768 | 0.030 |
Why?
| | Sirtuins | 1 | 2016 | 39 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2016 | 149 | 0.030 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2016 | 72 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2015 | 119 | 0.030 |
Why?
| | Female | 8 | 2004 | 75515 | 0.030 |
Why?
| | Glutathione Peroxidase | 1 | 1994 | 43 | 0.030 |
Why?
| | Catalase | 1 | 1994 | 134 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2015 | 92 | 0.030 |
Why?
| | N-Acetylneuraminic Acid | 1 | 1994 | 11 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2016 | 189 | 0.030 |
Why?
| | Ileum | 2 | 2006 | 112 | 0.030 |
Why?
| | Cholestanetriol 26-Monooxygenase | 2 | 2004 | 6 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 469 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 737 | 0.020 |
Why?
| | Histone Demethylases | 1 | 2012 | 31 | 0.020 |
Why?
| | Point Mutation | 2 | 2005 | 237 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 1994 | 352 | 0.020 |
Why?
| | Middle Aged | 4 | 1995 | 34434 | 0.020 |
Why?
| | Phylogeny | 3 | 2002 | 1018 | 0.020 |
Why?
| | Silver Nitrate | 1 | 2012 | 2 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2013 | 150 | 0.020 |
Why?
| | Zinc Sulfate | 1 | 2012 | 8 | 0.020 |
Why?
| | Silver Staining | 1 | 2012 | 17 | 0.020 |
Why?
| | Rosaniline Dyes | 1 | 2012 | 14 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2011 | 4208 | 0.020 |
Why?
| | Oxazines | 1 | 2012 | 32 | 0.020 |
Why?
| | Furans | 1 | 2012 | 24 | 0.020 |
Why?
| | Benzopyrans | 1 | 2012 | 27 | 0.020 |
Why?
| | Coloring Agents | 1 | 2012 | 96 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2015 | 725 | 0.020 |
Why?
| | Glycosylation | 1 | 2012 | 163 | 0.020 |
Why?
| | Ketones | 1 | 2012 | 51 | 0.020 |
Why?
| | Staining and Labeling | 1 | 2012 | 154 | 0.020 |
Why?
| | Obesity | 1 | 2004 | 3004 | 0.020 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2013 | 210 | 0.020 |
Why?
| | Adult | 4 | 1995 | 39177 | 0.020 |
Why?
| | Ligation | 1 | 2011 | 93 | 0.020 |
Why?
| | Vanadates | 1 | 1990 | 17 | 0.020 |
Why?
| | Glutathione Transferase | 1 | 2011 | 101 | 0.020 |
Why?
| | Ligands | 1 | 2013 | 667 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2012 | 112 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2011 | 154 | 0.020 |
Why?
| | Fatty Acids | 2 | 2004 | 448 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 1994 | 1398 | 0.020 |
Why?
| | Cell Nucleus | 2 | 2004 | 609 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2015 | 2180 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2015 | 660 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 324 | 0.020 |
Why?
| | In Situ Hybridization | 2 | 2002 | 320 | 0.020 |
Why?
| | Ochratoxins | 1 | 1989 | 2 | 0.020 |
Why?
| | Up-Regulation | 2 | 2004 | 859 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2002 | 391 | 0.020 |
Why?
| | Carbon Tetrachloride | 1 | 2009 | 13 | 0.020 |
Why?
| | Cloning, Molecular | 2 | 2002 | 533 | 0.020 |
Why?
| | Radionuclide Imaging | 1 | 2009 | 116 | 0.020 |
Why?
| | Metabolic Clearance Rate | 1 | 2009 | 116 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 1990 | 199 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2009 | 269 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2009 | 330 | 0.020 |
Why?
| | Dystonia Musculorum Deformans | 1 | 2008 | 3 | 0.020 |
Why?
| | Aniline Compounds | 1 | 2009 | 109 | 0.020 |
Why?
| | Tourette Syndrome | 1 | 2008 | 23 | 0.020 |
Why?
| | Glycine | 1 | 2009 | 182 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2009 | 454 | 0.020 |
Why?
| | Mutation | 2 | 2013 | 4013 | 0.020 |
Why?
| | Multigene Family | 1 | 2008 | 202 | 0.020 |
Why?
| | Estrone | 1 | 2007 | 36 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2008 | 400 | 0.020 |
Why?
| | Dimerization | 1 | 2007 | 196 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 6275 | 0.020 |
Why?
| | Xenopus laevis | 1 | 2006 | 107 | 0.020 |
Why?
| | Case-Control Studies | 1 | 1994 | 3588 | 0.020 |
Why?
| | Electrophysiology | 1 | 2006 | 217 | 0.010 |
Why?
| | Phosphorus Radioisotopes | 1 | 2005 | 27 | 0.010 |
Why?
| | Dogs | 1 | 2007 | 427 | 0.010 |
Why?
| | Autoradiography | 1 | 2005 | 69 | 0.010 |
Why?
| | Prognosis | 1 | 1994 | 4073 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 2005 | 74 | 0.010 |
Why?
| | Oocytes | 1 | 2006 | 179 | 0.010 |
Why?
| | Sodium | 1 | 2006 | 196 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 854 | 0.010 |
Why?
| | 5' Untranslated Regions | 1 | 2005 | 59 | 0.010 |
Why?
| | Molecular Weight | 1 | 2005 | 329 | 0.010 |
Why?
| | Rats, Zucker | 1 | 2004 | 33 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 2004 | 71 | 0.010 |
Why?
| | Immunosorbent Techniques | 1 | 2004 | 19 | 0.010 |
Why?
| | Alanine | 1 | 2005 | 153 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2005 | 219 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 859 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2005 | 368 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2007 | 672 | 0.010 |
Why?
| | Glucose | 1 | 1989 | 1041 | 0.010 |
Why?
| | Acetylation | 1 | 2004 | 245 | 0.010 |
Why?
| | Organ Size | 1 | 2004 | 478 | 0.010 |
Why?
| | Drug Synergism | 1 | 2004 | 375 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 2004 | 112 | 0.010 |
Why?
| | Gallbladder | 1 | 2003 | 15 | 0.010 |
Why?
| | Cytoplasm | 1 | 2004 | 273 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 232 | 0.010 |
Why?
| | Receptors, LDL | 1 | 2003 | 52 | 0.010 |
Why?
| | Somites | 1 | 2002 | 5 | 0.010 |
Why?
| | Protein Folding | 1 | 2004 | 278 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2003 | 412 | 0.010 |
Why?
| | Steroid 12-alpha-Hydroxylase | 1 | 2002 | 1 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2002 | 274 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2002 | 238 | 0.010 |
Why?
| | TATA Box | 1 | 2001 | 22 | 0.010 |
Why?
| | Neural Crest | 1 | 2002 | 121 | 0.010 |
Why?
| | Receptors, Retinoic Acid | 1 | 2001 | 41 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2005 | 698 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2002 | 159 | 0.010 |
Why?
| | Drainage | 1 | 2002 | 174 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2001 | 183 | 0.010 |
Why?
| | Rabbits | 1 | 2002 | 754 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2001 | 274 | 0.010 |
Why?
| | Mutagenesis | 1 | 2001 | 182 | 0.010 |
Why?
| | Tretinoin | 1 | 2001 | 122 | 0.010 |
Why?
| | Body Weight | 1 | 2004 | 996 | 0.010 |
Why?
| | DNA Primers | 1 | 2001 | 510 | 0.010 |
Why?
| | Genotype | 1 | 2004 | 1859 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2001 | 959 | 0.010 |
Why?
| | Sex Factors | 1 | 2004 | 2058 | 0.010 |
Why?
| | Fetus | 1 | 2003 | 802 | 0.010 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 1998 | 80 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1998 | 198 | 0.010 |
Why?
| | Codon | 1 | 1998 | 92 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2001 | 1357 | 0.010 |
Why?
| | Nervous System | 1 | 1998 | 68 | 0.010 |
Why?
| | DNA | 1 | 2004 | 1444 | 0.010 |
Why?
| | Embryo, Nonmammalian | 1 | 1998 | 169 | 0.010 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2001 | 353 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2003 | 631 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2003 | 2520 | 0.010 |
Why?
| | Mesoderm | 1 | 1998 | 144 | 0.010 |
Why?
| | Disease Progression | 1 | 2004 | 2793 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 3166 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2003 | 1764 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 1998 | 550 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1998 | 444 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1998 | 1056 | 0.010 |
Why?
| | Liver Neoplasms | 1 | 2001 | 740 | 0.010 |
Why?
| | Aging | 1 | 2003 | 1892 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1990 | 345 | 0.010 |
Why?
| | Liver Glycogen | 1 | 1989 | 16 | 0.000 |
Why?
| | Pregnancy | 1 | 2003 | 7070 | 0.000 |
Why?
| | Aspergillus | 1 | 1989 | 19 | 0.000 |
Why?
| | Pyruvates | 1 | 1989 | 24 | 0.000 |
Why?
| | Infant | 1 | 2004 | 9818 | 0.000 |
Why?
| | Lactates | 1 | 1989 | 85 | 0.000 |
Why?
| | Liver Function Tests | 1 | 1989 | 105 | 0.000 |
Why?
| | Child, Preschool | 1 | 2004 | 11457 | 0.000 |
Why?
| | Child | 1 | 2004 | 22308 | 0.000 |
Why?
| | Diet | 1 | 1989 | 1282 | 0.000 |
Why?
| | Blood Glucose | 1 | 1989 | 2269 | 0.000 |
Why?
| | Insulin | 1 | 1989 | 2482 | 0.000 |
Why?
|
|
Balasubramaniyan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|